Evidence map›Paper›PMID 23584437›Full record

Trial reportBone marrow transplantation2013

Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study.

W A Wood, A M Deal, B B Reeve, A P Abernethy, E Basch, S A Mitchell, C Shatten, Y Hie Kim, J Whitley, J S Serody and 2 more

3 registry-linked trialsAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03373526 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation

TypeinterventionalSponsorDaniel Godoy MartinezRan2017 to 2019Enrolled50ConditionsLymphoma, Myeloma, Leukemia, Aplastic AnemiaArmsInspiratory Muscle Training, Aerobic Training
NCT03992352 completednot on this mapstarted 2019, after this paper: background citation

Composite Health Assessment Risk Model (CHARM) for Older Adults: Applying Pre-Transplant Comorbidity, Geriatric Assessment, and BioMarkers on Non-Relapse Mortality After Allogeneic Transplant (BMT CTN 1704)

TypeobservationalSponsorCenter for International Blood and Marrow Transplant ResearchRan2019 to 2023Enrolled1,229ConditionsHematologic MalignancyArmsAge 60+ with planned HCT for Hematologic Malignancy
NCT06953648 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2025 to 2030Enrolled126ConditionsHematopoietic Stem Cell Transplantation, Cardiorespiratory FitnessArmsHigh Intensity Interval Training
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018
    Pooled it
  2. Trial
  3. Lessons learned from a pilot randomized clinical trial of home-based exercise prescription before allogeneic hematopoietic cell transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Exercise Prescription in Cardio-Oncology.Journal of clinical medicine · 2025
    Review
  10. Article
  11. Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  12. Allogeneic Transplantation for Older Adults.Advances in experimental medicine and biology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

W A WoodLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
A M Deal
B B Reeve
A P Abernethy
E Basch
S A Mitchell
C Shatten
Y Hie Kim
J Whitley
J S Serody
T Shea
C Battaglini
University of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer CenterDuke Medical Center · USEast Carolina University · USNational Cancer Institute · UA

Funding

UNC Clinical Translation Science Award-K12 Scholars Program (KL2)KL2TR000084 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2012 to 2013
$2.3M
NCATS NIH HHS KL2TR000084
6 · The paper itself

Abstract

Hematopoietic cell transplantation (HCT) is a life-saving treatment for patients with high-risk hematological malignancies. Prognostic measures to determine fitness for HCT are needed to inform decision-making and interventions. VO(2peak) is obtained by measuring gas exchange during cycle ergometry and has not been studied as a prognostic factor in HCT. Thirty-two autologous and allogeneic HCT patients underwent VO(2peak) and 6 Minute Walk (6MW) testing before HCT, and provided weekly symptom and health-related quality of life (HRQOL) assessments before HCT and concluding at Day 100. Twenty-nine patients completed pre-HCT testing. Pre-HCT VO(2peak) was positively correlated with pre-HCT 6MW (r=0.65, P<0.001) and negatively correlated with number of chemotherapy regimens and months of chemotherapy. Patients with lower VO(2peak) reported higher symptom burden and inferior HRQOL at baseline and during early post-HCT period. Patients with pre-HCT VO(2peak) <16 mL/kg/min had higher risk of mortality post HCT (entire cohort: hazard ratio (HR) 9.1 (1.75-47.0), P=0.01; allogeneic HCT patients only: HR 6.70 (1.29-34.75), P=0.02) and more hospitalized days before Day 100 (entire cohort: median 33 vs 19, P=0.003; allogeneic HCT patients only: median 33 vs 21, P=0.004). VO(2peak) pre-HCT is feasible and might predict symptom severity, HRQOL and mortality. Additional studies are warranted.

Indexed as

Cardiovascular Physiological PhenomenaAdultAgedExercise TestFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedOxygen ConsumptionPilot ProjectsQuality of LifeTransplantation ConditioningTransplantation, Homologous

Identifiers

PMID23584437
OpenAlexW1974790471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.